Oncology & Cancer

Combination approach to advanced cancer could improve survival

An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%.

Oncology & Cancer

Advancements in ctDNA detection promise improved lymphoma outcomes

A research team led by Prof. Gu Hongcang from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has published a comprehensive systematic review on circulating tumor DNA (ctDNA) technologies and their ...

Oncology & Cancer

SOX9 as a prognostic marker in gastric adenocarcinoma

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually. Unfortunately, many cases are detected at advanced stages due to the lack of clear early symptoms, ...

page 4 from 5